← Leaderboards
Marek Napierala
University Of Tx Md Anderson Can Ctr
$6,655,628
Attributed
$6,655,628
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $788.2K · FY2008–25$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,655,628 · 4
By mechanism
R01$5,696,261 · 2
R21$959,367 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Ataxia”
- Keri Hammel · The Emmes Company, Llc$41,748,603
- Supriya Menezes · The Emmes Company, Llc$25,277,032
- Harry T. Orr · University Of Minnesota Twin Cities$22,432,513
- Albert R La Spada · University Of Washington$20,439,172
- Stefan M. Pulst · Utah State Higher Education System--University Of Utah$15,678,126
- Huda Y Zoghbi · Baylor College Of Medicine$15,218,927
Research focus
AtaxiaGenesNeurodegenerative DisordersIntronsCellsFrataxinMolecularFriedreich AtaxiaBaseNeuronsInduced Pluripotent Stem CellAffectPathogenesisCell ModelEpigenetic ProcessInheritedGenetic TranscriptionCodeTrinucleotide RepeatsNovel Therapeutic InterventionLengthLinkMediatingMutant
Grant awards (22)
Defining the impact of Frataxin point mutations on Friedreich's ataxia pathogenesis$369,000
R01 · FY2025 · NS · contact PI
Defining the impact of Frataxin point mutations on Friedreich's ataxia pathogenesis$397,700
R01 · FY2024 · NS · contact PI
Defining the impact of Frataxin point mutations on Friedreich's ataxia pathogenesis$410,000
R01 · FY2023 · NS · contact PI
Defining the impact of Frataxin point mutations on Friedreich's ataxia pathogenesis$410,000
R01 · FY2022 · NS · contact PI
Defining the impact of Frataxin point mutations on Friedreich's ataxia pathogenesis$371,250
R01 · FY2021 · NS · contact PI
GAA REPEATS INDUCED EPIGENETIC SILENCING IN FRIEDREICH'S ATAXIA$338,571
R01 · FY2021 · NS · contact PI
GAA REPEATS INDUCED EPIGENETIC SILENCING IN FRIEDREICH'S ATAXIA$78,379
R01 · FY2021 · NS · contact PI
GAA REPEATS INDUCED EPIGENETIC SILENCING IN FRIEDREICH'S ATAXIA$416,950
R01 · FY2020 · NS · contact PI
GAA REPEATS INDUCED EPIGENETIC SILENCING IN FRIEDREICH'S ATAXIA$416,950
R01 · FY2019 · NS · contact PI
GAA REPEATS INDUCED EPIGENETIC SILENCING IN FRIEDREICH'S ATAXIA$416,950
R01 · FY2018 · NS · contact PI
New GAA expansion mouse for efficacy studies of treatments for Friedreich ataxia$345,404
R21 · FY2018 · NS · contact PI
GAA REPEATS INDUCED EPIGENETIC SILENCING IN FRIEDREICH'S ATAXIA$416,950
R01 · FY2017 · NS · contact PI
New GAA expansion mouse for efficacy studies of treatments for Friedreich ataxia$369,164
R21 · FY2017 · NS · contact PI
GAA Repeats Induced Epigenetic Silencing in Friedreich's Ataxia$321,563
R01 · FY2016 · NS · contact PI
GAA Repeats Induced Epigenetic Silencing in Friedreich's Ataxia$36,244
R01 · FY2016 · NS · contact PI
GAA Repeats Induced Epigenetic Silencing in Friedreich's Ataxia$321,563
R01 · FY2015 · NS · contact PI
GAA Repeats Induced Epigenetic Silencing in Friedreich's Ataxia$318,346
R01 · FY2014 · NS · contact PI
GAA Repeats Induced Epigenetic Silencing in Friedreich's Ataxia$310,220
R01 · FY2013 · NS · contact PI
GAA repeats induced epigenetic silencing in Friedreich's ataxia.$345,625
R01 · FY2012 · NS · contact PI
Targeting trinucleotide repeats-induced transcriptional silencing in Friedreich's$39,500
R21 · FY2011 · NS · contact PI
Targeting trinucleotide repeats-induced transcriptional silencing in Friedreich's$51,299
R21 · FY2010 · NS · contact PI
Targeting trinucleotide repeats-induced transcriptional silencing in Friedreich's$154,000
R21 · FY2008 · NS · contact PI